BEIJING & CAMBRIDGE, Mass. (BUSINESS WIRE) CANbridge Pharmaceuticals, Inc. (1228.HK), a China-based global biopharmaceutical company committed to the research, development and commercialization of transformative rare disease and rare oncology therapies, announced that it has appointed Pauline Li, MD, to the positi.
CANbridge Pharmaceuticals Appoints Pauline Li as Senior Vice President of Clinical Development and Operations - read this article along with other careers information, tips and advice on BioSpace
Hong Kong retail investors show strong intent on ESG investment, despite awareness and associated investment experience remaining miragenews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from miragenews.com Daily Mail and Mail on Sunday newspapers.
HKUST co-led survey shows HK investors have strong intent on ESG investment miragenews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from miragenews.com Daily Mail and Mail on Sunday newspapers.